-
1
-
-
50249230114
-
Prophylactic inoculation against hay fever
-
NOON L, CANTAB BC: Prophylactic inoculation against hay fever. Lancet (1911) 177:1572-1573.
-
(1911)
Lancet
, vol.177
, pp. 1572-1573
-
-
Noon, L.1
Cantab, B.C.2
-
2
-
-
0029820287
-
Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro
-
AKDIS CA, AKDIS M, BLESKEN T et al.: Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. (1996) 98:1676-1683.
-
(1996)
J. Clin. Invest.
, vol.98
, pp. 1676-1683
-
-
Akdis, C.A.1
Akdis, M.2
Blesken, T.3
-
3
-
-
4644360689
-
T regulatory cells in allergy and health: A question of allergen specificity and balance
-
TAYLOR A, VERHAGEN J, AKDIS CA, AKDIS M: T regulatory cells in allergy and health: a question of allergen specificity and balance. Int. Arch. Allergy Immunol. (2004) 135:73-82.
-
(2004)
Int. Arch. Allergy Immunol.
, vol.135
, pp. 73-82
-
-
Taylor, A.1
Verhagen, J.2
Akdis, C.A.3
Akdis, M.4
-
4
-
-
0033823657
-
Cytokines and chemokines in T lymphopoiesis and T-cell effector function
-
ROMAGNANI P, ANNUNZIATO F, PICCINNI MP, MAGGI E, ROMAGNANI S: Cytokines and chemokines in T lymphopoiesis and T-cell effector function. Immunol. Today (2000) 21:416-418.
-
(2000)
Immunol. Today
, vol.21
, pp. 416-418
-
-
Romagnani, P.1
Annunziato, F.2
Piccinni, M.P.3
Maggi, E.4
Romagnani, S.5
-
5
-
-
0032524991
-
Transplacental priming of the human immune system to environmental allergens: Universal skewing of initial T cell responses toward the Th2 cytokine profile
-
PRESCOTT SL, MACAUBAS C, HOLT BJ et al.: Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile. J. Immunol. (1998) 160:4730-4737.
-
(1998)
J. Immunol.
, vol.160
, pp. 4730-4737
-
-
Prescott, S.L.1
Macaubas, C.2
Holt, B.J.3
-
6
-
-
0033573788
-
Development of allergen-specific T-cell memory in atopic and normal children
-
PRESCOTT SL, MACAUBAS C, SMALLACOMBE T, HOLT BJ, SLY PD, HOLT PG: Development of allergen-specific T-cell memory in atopic and normal children. Lancet (1999) 353:196-200.
-
(1999)
Lancet
, vol.353
, pp. 196-200
-
-
Prescott, S.L.1
Macaubas, C.2
Smallacombe, T.3
Holt, B.J.4
Sly, P.D.5
Holt, P.G.6
-
7
-
-
0033961847
-
Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases
-
YSSEL H, GROUX H: Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases. Int. Arch. Allergy Immunol. (2000) 121:10-18.
-
(2000)
Int. Arch. Allergy Immunol.
, vol.121
, pp. 10-18
-
-
Yssel, H.1
Groux, H.2
-
8
-
-
0033932896
-
T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis
-
TRAUTMANN A, AKDIS M, KLEEMANN D et al.: T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J. Clin. Invest. (2000) 106:25-35.
-
(2000)
J. Clin. Invest.
, vol.106
, pp. 25-35
-
-
Trautmann, A.1
Akdis, M.2
Kleemann, D.3
-
10
-
-
0038387249
-
T helper (Th) 2 predominance in atopic disease is due to preferential apoptosis of circulating memory/effector Th1 cells
-
AKDIS M, TRAUTMANN A, KLUNKER S et al.: T helper (Th) 2 predominance in atopic disease is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J. (2003) 17:1026-1035.
-
(2003)
FASEB J.
, vol.17
, pp. 1026-1035
-
-
Akdis, M.1
Trautmann, A.2
Klunker, S.3
-
11
-
-
0028288179
-
Lymphokine production by human T cells in disease states
-
ROMAGNANI S: Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. (1994) 12:227-257.
-
(1994)
Annu. Rev. Immunol.
, vol.12
, pp. 227-257
-
-
Romagnani, S.1
-
12
-
-
0032749783
-
IL-13 in allergy: Home at last
-
CORRY DB: IL-13 in allergy: home at last. Curr. Opin. Immunol. (1999) 11:610-614.
-
(1999)
Curr. Opin. Immunol.
, vol.11
, pp. 610-614
-
-
Corry, D.B.1
-
13
-
-
0036240589
-
Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System
-
MOVERARE R, ELFMAN L, VESTERINEN E, METSO T, HAAHTELA T: Development of new IgE specificities to allergenic components in birch pollen extract during specific immunotherapy studied with immunoblotting and Pharmacia CAP System. Allergy (2002) 57:423-430.
-
(2002)
Allergy
, vol.57
, pp. 423-430
-
-
Moverare, R.1
Elfman, L.2
Vesterinen, E.3
Metso, T.4
Haahtela, T.5
-
14
-
-
2442648797
-
Allergen immunotherapy: Therapeutic vaccines for allergic diseases
-
World Health Organization. American Academy of Allergy, Asthma and Immunology
-
BOUSQUET J, LOCKEY R, MALLING HJ et al.: Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American Academy of Allergy, Asthma and Immunology. Ann. Allergy Asthma Immunol. (1998) 81:401-405.
-
(1998)
Ann. Allergy Asthma Immunol.
, vol.81
, pp. 401-405
-
-
Bousquet, J.1
Lockey, R.2
Malling, H.J.3
-
15
-
-
0038603844
-
Peptide immunotherapy for allergic disease
-
TARZI M, LARCHE M: Peptide immunotherapy for allergic disease. Expert Opin. Biol. Ther. (2003) 3:617-626.
-
(2003)
Expert Opin. Biol. Ther.
, vol.3
, pp. 617-626
-
-
Tarzi, M.1
Larche, M.2
-
16
-
-
0034665515
-
Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice
-
ASTORI M, VON GARNIER C, KETTNER A, DUFOUR N, CORRADIN G, SPERTINI F: Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice. J. Immunol. (2000) 165:3497-3505.
-
(2000)
J. Immunol.
, vol.165
, pp. 3497-3505
-
-
Astori, M.1
Von Garnier, C.2
Kettner, A.3
Dufour, N.4
Corradin, G.5
Spertini, F.6
-
17
-
-
0035462111
-
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1
-
VRTALA S, HIRTENLEHNER K, SUSANI M et al.: Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1. FASEB J. (2001) 15:2045-2047. Single amino acid mutations in recombinant allergens lead to hypoallergic variants by altering IgE epitopes.
-
(2001)
FASEB J.
, vol.15
, pp. 2045-2047
-
-
Vrtala, S.1
Hirtenlehner, K.2
Susani, M.3
-
18
-
-
0034544450
-
T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen. Bet v 1, induce blocking antibodies
-
VRTALA S, AKDIS CA, BUDAK F et al.: T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen. Bet v 1, induce blocking antibodies. J. Immunol. (2000) 165:6653-6659.
-
(2000)
J. Immunol.
, vol.165
, pp. 6653-6659
-
-
Vrtala, S.1
Akdis, C.A.2
Budak, F.3
-
19
-
-
0036676925
-
Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity
-
LINHART B, JAHN-SCHMID B, VERDINO P et al.: Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity. FASEB J. (2002) 16:1301-1303.
-
(2002)
FASEB J.
, vol.16
, pp. 1301-1303
-
-
Linhart, B.1
Jahn-Schmid, B.2
Verdino, P.3
-
20
-
-
0031952580
-
Modulation of IgE reactivity of allergens by site-directed mutagenesis: Potential use of hypoallergenic variants for immunotherapy
-
FERREIRA F, EBNER C, KRAMER B et al.: Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J. (1998) 12:231-242.
-
(1998)
FASEB J.
, vol.12
, pp. 231-242
-
-
Ferreira, F.1
Ebner, C.2
Kramer, B.3
-
21
-
-
0031866059
-
Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom
-
MULLER U, AKDIS CA, FRICKER M et al.: Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom. J. Allergy Clin. Immunol. (1998) 101:747-754. This is the first human short T cell epitope peptide immunotherapy, which shows allergen-specific T cell tolerance and regulation of IgG4 versus IgE ratios in favour of IgG4 1 week after contact with live bee stings.
-
(1998)
J. Allergy Clin. Immunol.
, vol.101
, pp. 747-754
-
-
Muller, U.1
Akdis, C.A.2
Fricker, M.3
-
22
-
-
0032783475
-
B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by gene fragmentation as candidates for immunotherapy
-
BALL T, FUCHS T, SPERR WR et al.: B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by gene fragmentation as candidates for immunotherapy. FASEB J. (1999) 13:1277-1290.
-
(1999)
FASEB J.
, vol.13
, pp. 1277-1290
-
-
Ball, T.1
Fuchs, T.2
Sperr, W.R.3
-
23
-
-
0026579897
-
Genetic immunization is a simple method for eliciting an immune response
-
TANG DC, DEVIT M, JOHNSTON SA: Genetic immunization is a simple method for eliciting an immune response. Nature (1992) 356:152-154.
-
(1992)
Nature
, vol.356
, pp. 152-154
-
-
Tang, D.C.1
Devit, M.2
Johnston, S.A.3
-
24
-
-
0029664297
-
Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization
-
RAZ E, TIGHE H, SATO Y et al.: Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl. Acad. Sci. USA (1996) 93:5141-5145.
-
(1996)
Proc. Natl. Acad. Sci. USA
, vol.93
, pp. 5141-5145
-
-
Raz, E.1
Tighe, H.2
Sato, Y.3
-
25
-
-
0029925502
-
Immunoprophylaxis of allergen-induced immunoglobulin e synthesis and airway hyperresponsiveness in vivo by genetic immunization
-
HSU CH, CHUA KY, TAO MH et al.: Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat. Med. (1996) 2:540-544.
-
(1996)
Nat. Med.
, vol.2
, pp. 540-544
-
-
Hsu, C.H.1
Chua, K.Y.2
Tao, M.H.3
-
26
-
-
0032944136
-
Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen
-
HARTL A, KIESSLICH J, WEISS R et al.: Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen. J. Allergy Clin. Immunol. (1999) 103:107-113.
-
(1999)
J. Allergy Clin. Immunol.
, vol.103
, pp. 107-113
-
-
Hartl, A.1
Kiesslich, J.2
Weiss, R.3
-
27
-
-
0034919063
-
The effect of vaccination with DNA encoding murine T-cell epitopes on the der p 1 and 2 induced imnmnoglobulin e synthesis
-
KWON SS, KIM N, YOO TJ: The effect of vaccination with DNA encoding murine T-cell epitopes on the Der p 1 and 2 induced imnmnoglobulin E synthesis. Allergy (2001) 56:741-748.
-
(2001)
Allergy
, vol.56
, pp. 741-748
-
-
Kwon, S.S.1
Kim, N.2
Yoo, T.J.3
-
28
-
-
0031716080
-
The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine
-
SLATER JE, PAUPORE E, ZHANG YT, COLBERG-POLEY AM: The latex allergen Hev b 5 transcript is widely distributed after subcutaneous injection in BALB/c mice of its DNA vaccine. J. Allergy Clin. Immunol. (1998) 102:469-475.
-
(1998)
J. Allergy Clin. Immunol.
, vol.102
, pp. 469-475
-
-
Slater, J.E.1
Paupore, E.2
Zhang, Y.T.3
Colberg-Poley, A.M.4
-
29
-
-
0000839580
-
The oral administration of pollen
-
BLACK J: The oral administration of pollen. J. Lab. Clin. Med. (1927) 12:1156.
-
(1927)
J. Lab. Clin. Med.
, vol.12
, pp. 1156
-
-
Black, J.1
-
30
-
-
0037340480
-
Noninjection routes for immunotherapy
-
CANONICA GW, PASSALACQUA G: Noninjection routes for immunotherapy. J. Allergy Clin. Immunol. (2003) 111:437-448. A comprehensive review of non-injection imunotherapy.
-
(2003)
J. Allergy Clin. Immunol.
, vol.111
, pp. 437-448
-
-
Canonica, G.W.1
Passalacqua, G.2
-
31
-
-
0026822349
-
Immunotherapy by inhalation of allergen in powder in house dust allergic asthma - A double-blind study
-
TARI MG, MANCINO M, MONTI G: Immunotherapy by inhalation of allergen in powder in house dust allergic asthma-a double-blind study. J. Investig. Allergol. Clin. Immunol. (1992) 2:59-67.
-
(1992)
J. Investig. Allergol. Clin. Immunol.
, vol.2
, pp. 59-67
-
-
Tari, M.G.1
Mancino, M.2
Monti, G.3
-
32
-
-
0025909578
-
Local immnnotherapy with Dermatophagoides extract in asthma
-
CRIMI E, VOLTOLINI S, TROISE C et al.: Local immnnotherapy with Dermatophagoides extract in asthma. J. Allergy Clin. Immunol. (1991) 87:721-728.
-
(1991)
J. Allergy Clin. Immunol.
, vol.87
, pp. 721-728
-
-
Crimi, E.1
Voltolini, S.2
Troise, C.3
-
33
-
-
0036959080
-
Is sublingual immunotherapy clinically effective?
-
MALLING HJ: Is sublingual immunotherapy clinically effective? Curr. Opin. Allergy Clin. Immunol. (2002) 2:523-531.
-
(2002)
Curr. Opin. Allergy Clin. Immunol.
, vol.2
, pp. 523-531
-
-
Malling, H.J.1
-
34
-
-
19344370528
-
Efficacy and safety of sublingual immunotherapy
-
quiz 12-13, 103
-
PASSALACQUA G, GUERRA L, PASQUALI M, LOMBARDI C, CANONICA GW: Efficacy and safety of sublingual immunotherapy. Ann. Allergy Asthma Immunol. (2004) 93:3-12; quiz 12-13, 103.
-
(2004)
Ann. Allergy Asthma Immunol.
, vol.93
, pp. 3-12
-
-
Passalacqua, G.1
Guerra, L.2
Pasquali, M.3
Lombardi, C.4
Canonica, G.W.5
-
35
-
-
16444365595
-
Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mite
-
BAHCECILER NN, ARIKAN C, TAYLOR A et al.: Impact of sublingual immunotherapy on specific antibody levels in asthmatic children allergic to house dust mite. Int. Arch. Allergy Immunol. (2005) 136(3):287-294.
-
(2005)
Int. Arch. Allergy Immunol.
, vol.136
, Issue.3
, pp. 287-294
-
-
Bahceciler, N.N.1
Arikan, C.2
Taylor, A.3
-
37
-
-
1642290976
-
Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy
-
ARIKAN C, BAHCECILER NN, DENIZ G et al.: Bacillus Calmette-Guerin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy. Clin. Exp. Allergy (2004) 34:398-405. This study demonstrates that BCG vaccine administered together with SLIT induces IL-12 production, without improving clinical outcome.
-
(2004)
Clin. Exp. Allergy
, vol.34
, pp. 398-405
-
-
Arikan, C.1
Bahceciler, N.N.2
Deniz, G.3
-
38
-
-
0031914629
-
Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae
-
WANG CC, ROOK GA: Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccae. Immunology (1998) 93:307-313.
-
(1998)
Immunology
, vol.93
, pp. 307-313
-
-
Wang, C.C.1
Rook, G.A.2
-
39
-
-
0036278230
-
Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells
-
ZUANY-AMORIM C, SAWICKA E, MANLIUS C et al.: Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. (2002) 8:625-629.
-
(2002)
Nat. Med.
, vol.8
, pp. 625-629
-
-
Zuany-Amorim, C.1
Sawicka, E.2
Manlius, C.3
-
40
-
-
0242303573
-
Inhibition of T helper 2-type responses, IgF, production and eosinophilia by synthetic lipopeptides
-
AKDIS CA, KUSSEBI F, PULENDRAN B et al.: Inhibition of T helper 2-type responses, IgF, production and eosinophilia by synthetic lipopeptides. Eur. J. Immunol. (2003) 33:2717-2726. TLR2-triggering immunostimulatory lipopeptides suppress IgE and lung eosinophilia, and induce IFN-γ and IL-10 production by T cells.
-
(2003)
Eur. J. Immunol.
, vol.33
, pp. 2717-2726
-
-
Akdis, C.A.1
Kussebi, F.2
Pulendran, B.3
-
41
-
-
2442681742
-
A novel approach to specific allergy treatment: The recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity
-
BOHLE B, BREITWIESER A, ZWOLFER B et al.: A novel approach to specific allergy treatment: the recombinant fusion protein of a bacterial cell surface (S-layer) protein and the major birch pollen allergen Bet v 1 (rSbsC-Bet v 1) combines reduced allergenicity with immunomodulating capacity. J. Immunol. (2004) 172:6642-6648.
-
(2004)
J. Immunol.
, vol.172
, pp. 6642-6648
-
-
Bohle, B.1
Breitwieser, A.2
Zwolfer, B.3
-
42
-
-
3042718066
-
Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA
-
SIMONS FE, SHIKISHIMA Y, VAN NEST G, EIDEN JJ, HAYGLASS KT: Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J. Allergy Clin. Immunol. (2004) 113:1 144-1151. Amb a 1-immunostimulatory DNA sequence conjugate SIT led to a prolonged shift from Th2 immunity towards Th1 immunity and appeared to be safe.
-
(2004)
J. Allergy Clin. Immunol.
, vol.113
, pp. 1144-1151
-
-
Simons, F.E.1
Shikishima, Y.2
Van Nest, G.3
Eiden, J.J.4
Hayglass, K.T.5
-
43
-
-
1842631153
-
Immunotherapeutic uses of CpG oligodeoxynucleotides
-
KLINMAN DM: Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. (2004) 4:249-258.
-
(2004)
Nat. Rev. Immunol.
, vol.4
, pp. 249-258
-
-
Klinman, D.M.1
-
44
-
-
0032921181
-
IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: Two key steps in specific immunotherapy
-
AKDIS CA, BLASER K: IL-10-induced anergy in peripheral T cell and reactivation by microenvironmental cytokines: two key steps in specific immunotherapy. FASEB J. (1999) 13:603-609.
-
(1999)
FASEB J.
, vol.13
, pp. 603-609
-
-
Akdis, C.A.1
Blaser, K.2
-
45
-
-
0032128421
-
Role of IL-10 in specific immunotherapy
-
AKDIS CA, BLESKEN T, AKDIS M, WÜTHRICH B, BLASER K: Role of IL-10 in specific immunotherapy. J. Clin. Invest. (1998) 102:98-106. This study shows that IL-10 plays a major role in T cell unresponsiveness.
-
(1998)
J. Clin. Invest.
, vol.102
, pp. 98-106
-
-
Akdis, C.A.1
Blesken, T.2
Akdis, M.3
Wüthrich, B.4
Blaser, K.5
-
46
-
-
0038363534
-
IL-10 and TGF-β cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy
-
JUTEL M, AKDIS M, BUDAK F et al.: IL-10 and TGF-β cooperate in regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. (2003) 33:1205-1214.
-
(2003)
Eur. J. Immunol.
, vol.33
, pp. 1205-1214
-
-
Jutel, M.1
Akdis, M.2
Budak, F.3
-
47
-
-
0029013533
-
Grass pollen immunotherapy: Efficacy and safety during a 4-year follow- up study
-
WALKER SM, VARNEY VA, GAGA M, JACOBSON MR, DURHAM SR: Grass pollen immunotherapy: efficacy and safety during a 4-year follow- up study. Allergy (1995) 50:405-413.
-
(1995)
Allergy
, vol.50
, pp. 405-413
-
-
Walker, S.M.1
Varney, V.A.2
Gaga, M.3
Jacobson, M.R.4
Durham, S.R.5
-
48
-
-
0025979907
-
Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs
-
VARNEY VA, GAGA M, FREW AJ, ABER VR, KAY AB, DURHAM SR: Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. Br. Med. J. (1991) 302:265-269.
-
(1991)
Br. Med. J.
, vol.302
, pp. 265-269
-
-
Varney, V.A.1
Gaga, M.2
Frew, A.J.3
Aber, V.R.4
Kay, A.B.5
Durham, S.R.6
-
49
-
-
0018875627
-
Generation of antigen-specific suppressor cells during allergy desensitization
-
ROCKLIN RE, SHEFFER AL, GREINEDER DK, MELMON KL: Generation of antigen-specific suppressor cells during allergy desensitization. N. Engl. J. Med. (1980) 302:1213-1219.
-
(1980)
N. Engl. J. Med.
, vol.302
, pp. 1213-1219
-
-
Rocklin, R.E.1
Sheffer, A.L.2
Greineder, D.K.3
Melmon, K.L.4
-
50
-
-
0022337169
-
Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy
-
CRETICOS PS, ADKINSON NF JR, KAGEY-SOBOTKA A et al.: Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J. Clin. Invest. (1985) 76:2247-2253.
-
(1985)
J. Clin. Invest.
, vol.76
, pp. 2247-2253
-
-
Creticos, P.S.1
Adkinson Jr., N.F.2
Kagey-Sobotka, A.3
-
51
-
-
0023722274
-
The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients
-
RAK S, LOWHAGEN O, VENGE P: The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J. Allergy Clin. Immunol. (1988) 82:470-480.
-
(1988)
J. Allergy Clin. Immunol.
, vol.82
, pp. 470-480
-
-
Rak, S.1
Lowhagen, O.2
Venge, P.3
-
52
-
-
0026093155
-
Changes in nasal metachromatic cells during allergen immunotherapy
-
OTSUKA H, MEZAWA A, OHNISHI M, OKUBO K, SEKI H, OKUDA M: Changes in nasal metachromatic cells during allergen immunotherapy. Clin. Exp. Allergy (1991) 21:1 15-119.
-
(1991)
Clin. Exp. Allergy
, vol.21
, pp. 115-119
-
-
Otsuka, H.1
Mezawa, A.2
Ohnishi, M.3
Okubo, K.4
Seki, H.5
Okuda, M.6
-
53
-
-
0036687715
-
Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody
-
FLICKER S, STEINBERGER P, NORDERHAUG L et al.: Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody. Eur. J. Immunol. (2002) 32:2156-2162.
-
(2002)
Eur. J. Immunol.
, vol.32
, pp. 2156-2162
-
-
Flicker, S.1
Steinberger, P.2
Norderhaug, L.3
-
54
-
-
0033197966
-
Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgF-facilitated allergen presentation
-
VAN NEERVEN RJ, WIKBORG T, LUND G et al.: Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgF-facilitated allergen presentation. J. Immunol. (1999) 163:2944-2952.
-
(1999)
J. Immunol.
, vol.163
, pp. 2944-2952
-
-
Van Neerven, R.J.1
Wikborg, T.2
Lund, G.3
-
55
-
-
0038363534
-
IL-10 and TGE-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy
-
JUTEL M, AKDIS M, BUDAK F et al.: IL-10 and TGE-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur. J. Immunol. (2003) 33:1205-1214.
-
(2003)
Eur. J. Immunol.
, vol.33
, pp. 1205-1214
-
-
Jutel, M.1
Akdis, M.2
Budak, F.3
-
56
-
-
0032128421
-
Role of interleukin 10 in specific immunotherapy
-
AKDIS GA, BLESKEN T, AKDIS M, WUTHRICH B, BLASER K: Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. (1998) 102:98-106.
-
(1998)
J. Clin. Invest.
, vol.102
, pp. 98-106
-
-
Akdis, G.A.1
Blesken, T.2
Akdis, M.3
Wuthrich, B.4
Blaser, K.5
-
57
-
-
2942685507
-
Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells
-
AKDIS M, VERHAGEN J, TAYLOR A et al.: Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. (2004) 199:1567-1575. One of the key issues in monoallergies is to understand why an individual develops an allergy to a single protein, while tolerating thousands of others. Tr1 cells consistently represent the dominant subset specific for common environmental allergens in healthy individuals; in contrast, there is a high frequency of allergen-specific Th2 cells in allergic individuals.
-
(2004)
J. Exp. Med.
, vol.199
, pp. 1567-1575
-
-
Akdis, M.1
Verhagen, J.2
Taylor, A.3
-
58
-
-
0029984767
-
Interleukin-10 regulation in normal subjects and patients with asthma
-
BORISH L, AARONS A, RUMBYRT J, CVIETUSA P, NEGRI J, WENZEL S: Interleukin-10 regulation in normal subjects and patients with asthma. J. Allergy Clin. Immunol. (1996) 97:1288-1296.
-
(1996)
J. Allergy Clin. Immunol.
, vol.97
, pp. 1288-1296
-
-
Borish, L.1
Aarons, A.2
Rumbyrt, J.3
Cvietusa, P.4
Negri, J.5
Wenzel, S.6
-
59
-
-
0031150153
-
T cells subsets and cytokines in allergic and non-allergic children. 11. Analysis and IL-5 and IL-10 mRNA expression and protein production
-
KONING H, NEIJENS HJ, BAERT MR, ORANJE AP, SAVELKOUL HF: T cells subsets and cytokines in allergic and non-allergic children. 11. Analysis and IL-5 and IL-10 mRNA expression and protein production. Cytokine (1997) 9:427-436.
-
(1997)
Cytokine
, vol.9
, pp. 427-436
-
-
Koning, H.1
Neijens, H.J.2
Baert, M.R.3
Oranje, A.P.4
Savelkoul, H.F.5
-
60
-
-
0036177295
-
Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice
-
HELLINGS PW, VANDENBERGHE P, KASRAN A et al.: Blockade of CTLA-4 enhances allergic sensitization and eosinophilic airway inflammation in genetically predisposed mice. Eur. J. Immunol. (2002) 32:585-594.
-
(2002)
Eur. J. Immunol.
, vol.32
, pp. 585-594
-
-
Hellings, P.W.1
Vandenberghe, P.2
Kasran, A.3
-
61
-
-
0033172973
-
Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high- dose tolerance in the trachea
-
HANEDA K, SANO K, TAMURA G et al.: Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high- dose tolerance in the trachea. Am. J. Respir. Cell Mol. Biol. (1999) 21:268-274.
-
(1999)
Am. J. Respir. Cell Mol. Biol.
, vol.21
, pp. 268-274
-
-
Haneda, K.1
Sano, K.2
Tamura, G.3
-
62
-
-
0031573204
-
Induction of tolerance by IL-10-treated dendritic cells
-
STEINBRINK K, WOLFL M, JONULEIT H, KNOP J, ENK AH: Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. (1997) 159:4772-4780.
-
(1997)
J. Immunol.
, vol.159
, pp. 4772-4780
-
-
Steinbrink, K.1
Wolfl, M.2
Jonuleit, H.3
Knop, J.4
Enk, A.H.5
-
63
-
-
0024445451
-
Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production
-
SONODA E, MATSUMOTO R, HITOSHI Y et al.: Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. (1989) 170:1415-1420.
-
(1989)
J. Exp. Med.
, vol.170
, pp. 1415-1420
-
-
Sonoda, E.1
Matsumoto, R.2
Hitoshi, Y.3
-
64
-
-
0032055598
-
IgE versus IgG4 production can be differentially regulated by IL-10
-
JEANNIN P, LECOANET S, DELNESTE Y, GAUCHAT JF, BONNEFOY JY: IgE versus IgG4 production can be differentially regulated by IL-10. J. Immunol. (1998) 160:3555-3561.
-
(1998)
J. Immunol.
, vol.160
, pp. 3555-3561
-
-
Jeannin, P.1
Lecoanet, S.2
Delneste, Y.3
Gauchat, J.F.4
Bonnefoy, J.Y.5
-
65
-
-
0004445079
-
Low-affinity IgE receptor (CD23) function on mouse B cells: Role in IgE-dependent antigen focusing
-
KEHRY MR, YAMASHITA LC: Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing. Proc. Natl. Acad. Sci. USA (1989) 86:7556-7560.
-
(1989)
Proc. Natl. Acad. Sci. USA
, vol.86
, pp. 7556-7560
-
-
Kehry, M.R.1
Yamashita, L.C.2
-
66
-
-
0030991751
-
Effect of transmembrane and cytoplasmic domains of IgE on the IgE response
-
ACHATZ G, NITSCHKE L, LAMERS MC: Effect of transmembrane and cytoplasmic domains of IgE on the IgE response. Science (1977) 276:409-411.
-
(1977)
Science
, vol.276
, pp. 409-411
-
-
Achatz, G.1
Nitschke, L.2
Lamers, M.C.3
-
67
-
-
4644265623
-
Transforming growth factor-beta 1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1a dendritic cells in vitro
-
ALLAM JP, KLEIN E, BIEBER T, NOVAK N: Transforming growth factor-beta 1 regulates the expression of the high-affinity receptor for IgE on CD34 stem cell-derived CD1a dendritic cells in vitro. J. Invest. Dermatol. (2004) 123:676-682.
-
(2004)
J. Invest. Dermatol.
, vol.123
, pp. 676-682
-
-
Allam, J.P.1
Klein, E.2
Bieber, T.3
Novak, N.4
-
68
-
-
9844241585
-
IgE responses to Dermatophagoides pteronyssinus native major allergens der p 1 and der p 2 during long-term specific immunotherapy
-
MASTRANDREA F, SERIO G, MINARDI A et al.: IgE responses to Dermatophagoides pteronyssinus native major allergens Der p 1 and Der p 2 during long-term specific immunotherapy. Allergy (1997) 52:1115-1119.
-
(1997)
Allergy
, vol.52
, pp. 1115-1119
-
-
Mastrandrea, F.1
Serio, G.2
Minardi, A.3
-
69
-
-
0035103661
-
Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: Significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity
-
PICHLER CE, HELBLING A, PICHLER WJ: Three years of specific immunotherapy with house-dust-mite extracts in patients with rhinitis and asthma: significant improvement of allergen-specific parameters and of nonspecific bronchial hyperreactivity. Allergy (2001) 56:301-306.
-
(2001)
Allergy
, vol.56
, pp. 301-306
-
-
Pichler, C.E.1
Helbling, A.2
Pichler, W.J.3
-
70
-
-
0025805857
-
T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma
-
WALKER C, VIRCHOW JC JR, BRUIJNZEEL PL, BLASER K: T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J. Immunol. (1991) 146:1829-1835.
-
(1991)
J. Immunol.
, vol.146
, pp. 1829-1835
-
-
Walker, C.1
Virchow Jr., J.C.2
Bruijnzeel, P.L.3
Blaser, K.4
-
71
-
-
0024323445
-
Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids
-
SCHLEIMER RP, DERSE CP, FRIEDMAN B et al.: Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids. J. Immunol. (1989) 143:1310-1327.
-
(1989)
J. Immunol.
, vol.143
, pp. 1310-1327
-
-
Schleimer, R.P.1
Derse, C.P.2
Friedman, B.3
-
72
-
-
0034671063
-
Antigen-specific T cell tolerance down-regulates mast cell responses in vivo
-
TRETER S, LUQMAN M: Antigen-specific T cell tolerance down-regulates mast cell responses in vivo. Cell. Immunol. (2000) 206:116-124.
-
(2000)
Cell. Immunol.
, vol.206
, pp. 116-124
-
-
Treter, S.1
Luqman, M.2
-
73
-
-
1142265867
-
Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability
-
SHIM YK, KIM BS, CHO SH, MIN KU, HONG SJ: Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability. Clin. Exp. Allergy (2003) 33:52-57.
-
(2003)
Clin. Exp. Allergy
, vol.33
, pp. 52-57
-
-
Shim, Y.K.1
Kim, B.S.2
Cho, S.H.3
Min, K.U.4
Hong, S.J.5
-
74
-
-
0030025471
-
Interleukin (IL)-10 Inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells
-
MARSHALL JS, LEAL-BERUMEN I, NIELSEN L, GLIBETIC M, JORDANA M: Interleukin (IL)-10 Inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J. Clin. Invest. (1996) 97:1122-1128.
-
(1996)
J. Clin. Invest.
, vol.97
, pp. 1122-1128
-
-
Marshall, J.S.1
Leal-Berumen, I.2
Nielsen, L.3
Glibetic, M.4
Jordana, M.5
-
75
-
-
0028181890
-
B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10
-
SCHANDANE L, ALONSO-VEGA C, WILLEMS F et al.: B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. (1994) 152:4368-4374.
-
(1994)
J. Immunol.
, vol.152
, pp. 4368-4374
-
-
Schandane, L.1
Alonso-Vega, C.2
Willems, F.3
|